Article Details

Vaccitech, startup behind Oxford Covid vaccine tech, falls 20% in Nasdaq debut

Retrieved on: 2021-04-30 16:52:30

Tags for this article:

Click the tags to see associated articles and topics

Vaccitech, startup behind Oxford Covid vaccine tech, falls 20% in Nasdaq debut. View article details on hiswai:

Excerpt

American depositary shares of Vaccitech fell nearly 20% in their Nasdaq debut on Friday, giving the co-inventor of the Covid-19 vaccine developed by ...

Article found on: www.livemint.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo